The 310 Shares of Stock are sold by Monsanto Co. (MON) EVP Steven Mizell

The 310 Shares of Stock are sold by Monsanto Co. (MON) EVP Steven Mizell

Monsanto Co. (NYSE:MON) EVP Steven Mizell sold 310 shares of the business’s stock in a transaction on Monday, October 10th. The shares were sold at an average price of $103.09, for a total transaction of $31,957.90. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Shares of Monsanto Co. (NYSE:MON) opened at 102.32 on Thursday. The stock has a 50 day moving average of $104.66 and a 200-day moving average of $101.70. The stock has a market capitalization of $44.79 billion, a P/E ratio of 34.24 and a beta of 1.19. Monsanto Co. has a one year low of $83.73 and a one year high of $114.26.

Monsanto (NYSE:MON) last released its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.09. The business had revenue of $2.56 billion for the quarter, compared to analysts’ expectations of $2.38 billion. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The company’s revenue was up 8.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.19) EPS. Equities analysts forecast that Monsanto Co. will post $4.89 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, October 7th will be issued a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a dividend yield of 2.11%. The ex-dividend date of this dividend is Wednesday, October 5th. Monsanto’s dividend payout ratio is currently 71.05%.

MON has been the topic of several research reports. Sanford C. Bernstein upgraded shares of Monsanto from an “underperform” rating to a “market perform” rating and upped their price objective for the stock from $82.81 to $105.00 in a report on Monday, September 26th. Goldman Sachs Group Inc. set a $92.00 price objective on shares of Monsanto and gave the stock a “sell” rating in a report on Monday, June 27th. Jefferies Group restated a “buy” rating on shares of Monsanto in a report on Tuesday, September 6th. Citigroup Inc. upped their price objective on shares of Monsanto from $112.00 to $116.00 and gave the stock a “neutral” rating in a report on Friday, August 19th. Finally, Zacks Investment Research upgraded shares of Monsanto from a “strong sell” rating to a “hold” rating in a report on Tuesday, September 6th. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $114.65.

Large investors have recently added to or reduced their stakes in the company. Edmond DE Rothschild Holding S.A. boosted its stake in Monsanto by 3.2% in the first quarter. Edmond DE Rothschild Holding S.A. now owns 4,850 shares of the company’s stock worth $426,000 after buying an additional 150 shares in the last quarter. Meeder Asset Management Inc. boosted its stake in Monsanto by 1,962.5% in the first quarter. Meeder Asset Management Inc. now owns 8,250 shares of the company’s stock worth $724,000 after buying an additional 7,850 shares in the last quarter. State Street Corp boosted its stake in Monsanto by 0.9% in the first quarter. State Street Corp now owns 18,623,044 shares of the company’s stock worth $1,634,002,000 after buying an additional 173,201 shares in the last quarter. OMERS ADMINISTRATION Corp boosted its stake in Monsanto by 6.8% in the first quarter. OMERS ADMINISTRATION Corp now owns 679,300 shares of the company’s stock worth $59,602,000 after buying an additional 43,100 shares in the last quarter. Finally, Canada Pension Plan Investment Board boosted its stake in Monsanto by 1,769.4% in the first quarter. Canada Pension Plan Investment Board now owns 942,942 shares of the company’s stock worth $82,734,000 after buying an additional 892,500 shares in the last quarter. Institutional investors and hedge funds own 79.02% of the company’s stock.

Monsanto Company Profile

Related posts

Leave a Comment